1Kivela T. The epidemiological challenge of the most frequent eye cancer: retinobtastoma, an issue of birth and death [ J ]. Br J Oph- thalmol,2009,93(9) :1129 - 1131.
2Broaddus E,Topham A, Singh AD. Survival with retinoblastoma in the USA : 1975 - 2004 [ J]. Br J Ophthalmol, 2009,93 ( 1 ) : 24 - 27.
4Ghassemi F, Khodabande A. Risk definition and management strat-egies in retinoblastoma: current perspectives [ J ]. Clin Ophthal- mol,2015,9:985.
5Schiedler V, Dubovy SR, Murray TG. Snare technique for enuclea- tion of eyes with advanced retinoblastoma [ J ]. Arch Ophthalmol, 2007,125 (5) :680 - 683.
6Mendoza PR, Grossniklaus HE. Therapeutic options for retinoblas- toma[ J ]. Cancer Control,2016,23 (2) :99 - 109.
7Short BG. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations [ J ]. Toxicol Pathol,2008, 36( 1 ) :49 -62.
8Shields CL, Manjandavida FP, Lally SE, et al. Intra-arterial chemo- therapy for retinoblastoma in 70 eyes : outcomes based on the inter- national classification of retinoblastoma [ J ]. Ophthalmology, 2014,121 (7) : 1453 - 1460.
9Francis JH, Schaiquevich P, Buitrago E, et al. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblas- toma: a preclinical and clinical study [ J ]. Ophthalmology, 2014, 121(9) :1810 -1817.
10Orman A, Kom-Sengul T, Miao F, et al. The modem role of radia- tion therapy in treating advanced-stage retinoblastoma : long-term outcomes and racial differences[ J]. Int J Radiat Oncol Biol Phys- ics,2014,90(5) :1037 - 1043.
9Abramson DH. Retinoblastoma in the 20th century:past success and future challenges the Weisenfeld lecture [ J ]. Invest Ophthal- tool Vis Sei ,2005 ,46 :2684 -2691.
10Mouratova T. Eye cancer in adults in Uzbekistan, 1978 - 1998 [ J ]. Bull Soc Beige Ophtalmo1,2004 ,294 :25 - 34.
